This trial is testing whether a new treatment for prostate cancer, called Prostatic Artery Embolization (PAE), is effective. PAE will be given to patients before they start radiation therapy. Patients will be followed for six and twelve weeks after PAE to see how well the treatment works.
- Prostate Cancer
- Enlarged Prostate
1 Primary · 2 Secondary · Reporting Duration: At 12 weeks
1 Treatment Group
Prostatic Artery Embolization (PAE)
1 of 1
26 Total Participants · 1 Treatment Group
Primary Treatment: Radiation Therapy · No Placebo Group · Phase 2
Who is running the clinical trial?
Age 18+ · Male Participants · 6 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Are there any vacancies for individuals interested in participating in this research?
"Per the information on clinicaltrials.gov, this medical study is currently recruiting participants. It was initially posted in February of 2022 and most recently updated at the end of August that same year." - Anonymous Online Contributor
Has Radiation Therapy been officially validated by the FDA?
"With only some data indicating safety, we have assessed radiation therapy as having a rating of 2. Due to being in Phase 2 clinical trials, there is no evidence supporting its efficacy yet." - Anonymous Online Contributor
What is the aggregate number of people participating in this research?
"Affirmative. The clinical trial is actively enrolling patients, as evidenced by the information posted on clinicialtrials.gov; it was created on February 23rd 2022 and most recently revised August 18th of this year. A total of 26 participants are needed for the experiment to be conducted at a single site." - Anonymous Online Contributor